KOPP INVESTMENT ADVISORS LLC - ARRAY BIOPHARMA INC ownership

ARRAY BIOPHARMA INC's ticker is ARRY and the CUSIP is 04269X105. A total of 152 filers reported holding ARRAY BIOPHARMA INC in Q2 2015. The put-call ratio across all filers is 0.81 and the average weighting 0.2%.

Quarter-by-quarter ownership
KOPP INVESTMENT ADVISORS LLC ownership history of ARRAY BIOPHARMA INC
ValueSharesWeighting
Q2 2018$1,143,000
-2.1%
68,130
-4.8%
1.07%
-9.7%
Q1 2018$1,168,000
-19.0%
71,594
-36.5%
1.19%
-17.8%
Q4 2017$1,442,000
-2.0%
112,662
-5.8%
1.44%
+7.1%
Q3 2017$1,471,000
+45.2%
119,579
-1.2%
1.35%
+48.6%
Q2 2017$1,013,000
-8.2%
121,074
-1.9%
0.91%
-15.9%
Q1 2017$1,104,000
-42.9%
123,467
-43.9%
1.08%
-47.1%
Q4 2016$1,933,000
-13.0%
219,926
-33.2%
2.04%
-7.1%
Q3 2016$2,223,000
+73.3%
329,282
-8.6%
2.20%
+222.1%
Q2 2016$1,283,000
+16.3%
360,282
-3.6%
0.68%
+13.3%
Q1 2016$1,103,000
-30.6%
373,857
-0.7%
0.60%
-22.9%
Q4 2015$1,589,000
-8.7%
376,477
-1.4%
0.78%
-16.6%
Q3 2015$1,741,000
-37.0%
381,777
-0.3%
0.94%
-23.9%
Q2 2015$2,762,000
-1.7%
383,022
+0.5%
1.23%
-1.0%
Q1 2015$2,809,000
-1.0%
381,197
-36.5%
1.24%
-8.9%
Q4 2014$2,838,000
-60.4%
600,057
-70.1%
1.36%
-61.5%
Q3 2014$7,160,000
-22.0%
2,005,410
-0.3%
3.54%
-15.9%
Q2 2014$9,174,000
-11.3%
2,011,900
-8.6%
4.22%
-2.9%
Q1 2014$10,346,000
-7.3%
2,201,265
-1.2%
4.34%
-14.1%
Q4 2013$11,165,000
-36.1%
2,228,628
-20.6%
5.05%
-21.3%
Q3 2013$17,470,000
+7.3%
2,808,537
-21.7%
6.42%
+0.9%
Q2 2013$16,286,0003,587,1286.36%
Other shareholders
ARRAY BIOPHARMA INC shareholders Q2 2015
NameSharesValueWeighting ↓
Redmile Group, LLC 15,978,580$268,121,0009.11%
BVF INC/IL 4,672,195$78,399,0007.65%
First Light Asset Management, LLC 2,391,575$40,131,0006.25%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 694,500$11,647,0004.47%
Copernicus Capital Management, LLC 286,797$4,812,0003.49%
PACIFIC VIEW ASSET MANAGEMENT, LLC 225,511$3,784,0003.00%
SECTORAL ASSET MANAGEMENT INC 1,566,477$26,285,0002.94%
X-Square Capital, LLC 173,802$2,917,0002.18%
DRIEHAUS CAPITAL MANAGEMENT LLC 2,618,654$43,941,0001.48%
Birchview Capital, LP 128,000$2,148,0001.46%
View complete list of ARRAY BIOPHARMA INC shareholders